Skip to content

Clinical trials

Rare Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Country / region: Italy Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20061
20133
20152
20161
20183
20191
20201
20215
20222
202314
20245
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting14
Active, not recruiting7
Unknown status5
Terminated4
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Policlinico S. Donato10
Associazione Angela Serra per la ricerca sul cancro3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Istituto Ortopedico Rizzoli3
Novartis Pharmaceuticals3
Friedreich's Ataxia Research Alliance2
Istituti Clinici Scientifici Maugeri SpA2
Laboratoire français de Fractionnement et de Biotechnologies2
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases50
Marfan Syndrome6
Genetic Diseases, Inborn5
Aortic Aneurysm, Thoracic3
Friedreich Ataxia3
Huntington Disease3
Neurodegenerative Diseases3
Peripheral Nervous System Diseases3
Angioedemas, Hereditary2
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.